IncFact
Company Profiles: Revenue, Growth, Competition

INCYTE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Incyte

Access the complete profile.

Incyte Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address1801 Augustine Cut-off
Wilmington, DE 19803

www.incyte.com


Incyte's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Incyte's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Incyte is a publicly traded company on using the ticker symbol INCY. Detailed information on company financials and operating reports can be found here: : INCY



Incyte Annual Revenue and Growth Rate

Incyte Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Incyte's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Incyte is developing and marketing. Incyte's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
INIVIP
pharmaceutical preparations for the treatment and prevention of cancer, oncological disorders, autoimmune disorders, inflammation and inflammatory disorders, hematological disorders, respiratory and infectious diseases, tissue and organ transplant rejection, dermatological disorders, connective tissue disorders, musculo-skeletal disorders, and ophthalmology disorders
05/15/2020
ZULVIDA
pharmaceutical preparations for the treatment and prevention of cancer, oncological disorders, autoimmune disorders, inflammation and inflammatory disorders, hematological disorders, respiratory and infectious diseases, tissue and organ transplant rejection, dermatological disorders, connective tissue disorders, musculo-skeletal disorders, and ophthalmology disorders
05/15/2020
INZYL
pharmaceutical preparations for the treatment and prevention of cancer, oncological disorders, autoimmune disorders, inflammation and inflammatory disorders, hematological disorders, respiratory and infectious diseases, tissue and organ transplant rejection, dermatological disorders, connective tissue disorders, musculo-skeletal disorders, and ophthalmology disorders
05/15/2020

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Incyte grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Incyte is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Incyte's Largest Competitors

A competitive analysis shows these companies are in the same general field as Incyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to Incyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
INCYTEWilmington, DE100 
INTERDIGITAL COMMUNICATIONSWilmington, DE3 
ROSETTA GENOMICSWilmington, DE1 
PRELUDE THERAPEUTICSWilmington, DE1 
ADVANCED MATERIALS TECHNOLOGYWilmington, DE0 
ANALYTICAL BIOLOGICAL SERVICESWilmington, DE0 




Future Competition: Incyte's Fastest Growing Competitors

These companies are in the same general field as Incyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Incyte Competitors